PCCA's FormulaPlus™ program studies the beyond-use date (BUD) of compounded sterile and nonsterile formulas. In compliance with the latest revisions to USP, FormulaPlus studies are designed to evaluate the chemical potency of a formula over time utilizing stability-indicating assays and include USP 51 antimicrobial effectiveness testing where applicable. Many BUD formulas include bracketed studies, which tests low and high concentrations of the active pharmaceutical ingredient, allowing for customization of a formula between the two strengths.
The pipeline for FormulaPlus studies is driven by requests from our clients. Click below to connect with our team about PCCA studying your formula requests.